CORPORATE NEWS

Slovakofarma affected by forex fluctuations

Slovakia's largest drug producer, Slovakofarma a.s., said on April 27 it had to reduce dividends to 120 Sk per share from 220 Sk in 1996 due to a decline in its 1997 consolidated after-tax profit, which was 403 million Sk ($11.6 million), 27% lower than in 1996. The company officials blamed lower 1997 profits on losses from foreign exchange fluctuations, particularly the depreciation of the Czech crown. "In 1997, the devaluation of the Czech crown had an adverse impact on the company's results. In 1998, the company expects that the Czech authorities...will increase prices of pharmaceuticals," Slovakofarma said in a statement. Exports to the Czech Republic totalled 2.87 billion Sk in 1997, more than half of Slovakofarma's overall consolidated sales of 5.356 billion.

Get daily Slovak news directly to your inbox

Top stories

Here's what the across-the-board coronavirus testing should look like

The Defence Ministry introduced the basic steps of the planned testing.

Bratislava is testing special trolleybus

Public transport should become greener in the capital.

Bratislava borroved the hybrid trolleybus from the Czech city of České Budějovice for a week.

Teachers trust conspiracy media, they think the government is not handling the pandemic well

One-third of teachers think the coronavirus vaccination is a preparation for implanting chips, recent poll shows.

The school in Trenčianske Stankovce.

Ombudswoman, summer festival and a scientist. The awards for sustainable development have been granted

The Pontis Foundation awarded organisations, institutions and individuals for the second time.